These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 18662087)
21. Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia. Chen H; Wu S; Tang M; Zhao R; Zhang Q; Dai Z; Gao Y; Yang S; Li Z; Du Y; Yang A; Zhong L; Lu L; Xu L; Shen X; Liu S; Zhong J; Li X; Lu H; Xiong H; Shen Y; Chen H; Gong S; Xue H; Ge Z N Engl J Med; 2023 Nov; 389(18):1649-1659. PubMed ID: 37913505 [TBL] [Abstract][Full Text] [Related]
22. Thalidomide for treatment of gastrointestinal bleedings due to angiodysplasia: a case report in acquired von Willebrand syndrome and review of the literature. Engelen ET; van Galen KP; Schutgens RE Haemophilia; 2015 Jul; 21(4):419-29. PubMed ID: 25929157 [TBL] [Abstract][Full Text] [Related]
23. Successful Treatment of Recurrent Gastrointestinal Bleeding Due to Small Intestine Angiodysplasia and Multiple Myeloma with Thalidomide: Two Birds with One Stone. Hude I; Batinić J; Kinda SB; Pulanić D Turk J Haematol; 2018 Nov; 35(4):305-306. PubMed ID: 29911985 [No Abstract] [Full Text] [Related]
24. Type IIb von Willebrand disease with angiodysplasias and refractory gastrointestinal bleeding successfully treated with thalidomide. Nomikou E; Tsevrenis V; Gafou A; Bellia M; Theodossiades G Haemophilia; 2009 Nov; 15(6):1340-2. PubMed ID: 19702883 [No Abstract] [Full Text] [Related]
25. Beneficial effects and reversion of vascular lesions by thalidomide in a patient with bleeding portal hypertensive enteropathy. Jimenez-Saenz M; Romero-Vazquez J; Caunedo-Alvarez A; Maldonado-Perez B; Gutierrez JM Dig Liver Dis; 2010 Mar; 42(3):232-3. PubMed ID: 19574114 [No Abstract] [Full Text] [Related]
26. Long-term treatment with thalidomide for severe recurrent hemorrhage from intestinal angiodysplasia in Glanzmann Thrombasthenia. Paciullo F; Fierro T; Calcinaro F; Zucca Giucca G; Gresele P; Bury L Platelets; 2021 Feb; 32(2):288-291. PubMed ID: 32200672 [TBL] [Abstract][Full Text] [Related]
27. Cessation of recurrent bleeding from gastrointestinal angiodysplasia, after beta blocker treatment in a patient with hypertrophic subaortic stenosis--a case history. Schwartz J; Rozenfeld V; Habot B Angiology; 1992 Mar; 43(3 Pt 1):244-8. PubMed ID: 1575371 [TBL] [Abstract][Full Text] [Related]
28. Somatostatin in the treatment of gastrointestinal bleeding caused by angiodysplasia. Andersen MR; Aaseby J Scand J Gastroenterol; 1996 Oct; 31(10):1037-9. PubMed ID: 8898427 [TBL] [Abstract][Full Text] [Related]
29. Recurrent jejunal bleeding due to angiodysplasia in a Bernard-Soulier patient. Otrock ZK; Degheili JA; Sibai H; Salem ZM Blood Coagul Fibrinolysis; 2013 Jun; 24(4):428-9. PubMed ID: 23591164 [TBL] [Abstract][Full Text] [Related]
30. Success of estrogen-progesterone therapy in long-standing bleeding gastrointestinal angiodysplasia. Report of a case. Moshkowitz M; Arber N; Amir N; Gilat T Dis Colon Rectum; 1993 Feb; 36(2):194-6. PubMed ID: 8425426 [TBL] [Abstract][Full Text] [Related]
31. [Octreotide in bleeding caused by intestinal angiodysplasia]. Lourdes Ruiz Rebollo M; Barrio Andrés J; Fernández-Orcajo P; Prada Lobato J; Mena Martín FJ; Velicia Llames R; Caro-Paton A Gastroenterol Hepatol; 2008 Dec; 31(10):713-4. PubMed ID: 19174089 [No Abstract] [Full Text] [Related]
32. Angiodysplasia of the appendix. Kyokane T; Akita Y; Katayama M; Kitagawa Y; Sato T; Shichino S; Nimura Y Am J Gastroenterol; 2001 Jan; 96(1):242-4. PubMed ID: 11197261 [TBL] [Abstract][Full Text] [Related]
33. Recent advances in the treatment of refractory gastrointestinal angiodysplasia. Becq A; Sidhu R; Goltstein LCMJ; Dray X United European Gastroenterol J; 2024 Oct; 12(8):1128-1135. PubMed ID: 39229890 [TBL] [Abstract][Full Text] [Related]
34. Pharmacotherapy for Gastrointestinal Angiodysplasia: is it effective? Johnson CM; Nandi N; Sidhu R Expert Opin Pharmacother; 2024 Apr; 25(6):633-636. PubMed ID: 38682489 [No Abstract] [Full Text] [Related]
35. Risk factors for recurrence of acute gastrointestinal bleeding from angiodysplasia. Saperas E; Videla S; Dot J; Bayarri C; Lobo B; Abu-Suboh M; Armengol JR; Malagelada JR Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1333-9. PubMed ID: 19512936 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological treatment of gastrointestinal bleeding due to angiodysplasias: A position paper of the Italian Society of Gastroenterology (SIGE). Nardone G; Compare D; Martino A; Rocco A Dig Liver Dis; 2018 Jun; 50(6):542-548. PubMed ID: 29610020 [TBL] [Abstract][Full Text] [Related]
37. Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review. Almadi M; Ghali PM; Constantin A; Galipeau J; Szilagyi A Can J Gastroenterol; 2009 Sep; 23(9):625-31. PubMed ID: 19816627 [TBL] [Abstract][Full Text] [Related]
38. Thalidomide for the treatment of angiodysplasia in a patient with acute upper gastrointestinal haemorrhage. Bond A; Ahmed W BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791122 [TBL] [Abstract][Full Text] [Related]
39. Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide. Bauditz J; Lochs H; Voderholzer W Endoscopy; 2006 Oct; 38(10):1036-9. PubMed ID: 17058171 [TBL] [Abstract][Full Text] [Related]
40. Somatostatin therapy ameliorates chronic and refractory gastrointestinal bleeding caused by diffuse angiodysplasia in a patient on anticoagulation therapy. Blich M; Fruchter O; Edelstein S; Edoute Y Scand J Gastroenterol; 2003 Jul; 38(7):801-3. PubMed ID: 12889571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]